However, at this juncture, we decline to suppress the Electronic Case Reporting measure beyond the CY 2025 performance period and the EHR reporting period in CY 2025 without more specific information regarding the extent of the effect, if any, the existing circumstance will have on the CY 2026 performance period/EHR reporting period in CY 2026
The effect of the medication is temporary and completely reversible once the medication is stopped
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
She brings a strong clinical background paired with a warm, patient-centered approach to wellness care
Nakagaki K, Ebihara S, Usui S, Honda Y, Takahashi Y, Kato N
These include type 2 diabetes [417,418], heart failure [419], myocarditis [420], peripheral arterial disease [421], various disorders of pregnancy [422], and others that are not always (but should be) seen to be associated with vascular problems, such as Alzheimers and Parkinsons [423]